rs751855814
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_000197.2(HSD17B3):c.824C>T(p.Ala275Val) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000496 in 1,612,516 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/24 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. A275A) has been classified as Likely benign.
Frequency
Consequence
NM_000197.2 missense, splice_region
Scores
Clinical Significance
Conservation
Publications
- 46,XY disorder of sex development due to 17-beta-hydroxysteroid dehydrogenase 3 deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HSD17B3 | NM_000197.2 | c.824C>T | p.Ala275Val | missense_variant, splice_region_variant | Exon 11 of 11 | ENST00000375263.8 | NP_000188.1 | |
SLC35D2-HSD17B3 | NR_182427.1 | n.3591C>T | splice_region_variant, non_coding_transcript_exon_variant | Exon 26 of 26 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HSD17B3 | ENST00000375263.8 | c.824C>T | p.Ala275Val | missense_variant, splice_region_variant | Exon 11 of 11 | 1 | NM_000197.2 | ENSP00000364412.3 | ||
ENSG00000285269 | ENST00000643789.1 | n.*2500C>T | splice_region_variant, non_coding_transcript_exon_variant | Exon 22 of 22 | ENSP00000494818.1 | |||||
ENSG00000285269 | ENST00000643789.1 | n.*2500C>T | 3_prime_UTR_variant | Exon 22 of 22 | ENSP00000494818.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152218Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000320 AC: 8AN: 249800 AF XY: 0.0000370 show subpopulations
GnomAD4 exome AF: 0.0000534 AC: 78AN: 1460298Hom.: 0 Cov.: 30 AF XY: 0.0000523 AC XY: 38AN XY: 726476 show subpopulations
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152218Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74360 show subpopulations
ClinVar
Submissions by phenotype
not provided Uncertain:1
This sequence change replaces alanine with valine at codon 275 of the HSD17B3 protein (p.Ala275Val). The alanine residue is moderately conserved and there is a small physicochemical difference between alanine and valine. This variant is present in population databases (rs751855814, ExAC 0.008%). This variant has not been reported in the literature in individuals with HSD17B3-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at